Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Part of paid clinical trials in Tucson, Arizona.
- Sponsor
- GlaxoSmithKline
- Study ID
- NCT00005865
- Phase
- PHASE2
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- vinorelbine tartrate — DRUG
Study Details
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving drugs in different ways may kill more tumor cells. It is not yet known whether giving vinorelbine by mouth or infusion is more effective in treating non- small cell lung cancer. PURPOSE: Randomized phase II trial to compare the effectiveness of vinorelbine given by mouth or as an infusion in treating patients who have stage IIIB or stage IV non-small cell lung cancer.
Key Dates
- Start date
- Apr 30, 2000
- Status verified
- Jun 2007
- Completion
- Jun 30, 2007
Study Design
- Allocation
- RANDOMIZED
- Primary purpose
- TREATMENT
Locations (46)
Find similar trials in Tucson, AZ
By condition
By specialty
Related Studies
- Detection of Genetic Markers of Lung CancerRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Lung Cancer Biomarkers and ScreeningRecruiting · NYU Langone Health · New York, New York
- DNA Analysis of Blood and Tissue from Patients with Lung CancerRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung CancersRecruiting · Stanford University · Stanford, California